A look at Esperion Therapeutics Inc’s (ESPR) recent performance gives investors their first glimpse of hope.
On Monday, Esperion Therapeutics Inc (NASDAQ: ESPR) was -1.38% drop from the session before settling in for the closing price of $0.92. A 52-week range